Kolon Life Science (XKRX:102940) Other Net Income (Loss) : ₩115 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Kolon Life Science Other Net Income (Loss)?

Kolon Life Science's Other Net Income (Loss) for the three months ended in Mar. 2024 was ₩0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩115 Mil.

Kolon Life Science's quarterly Other Net Income (Loss) declined from Sep. 2023 (₩0 Mil) to Dec. 2023 (₩-53 Mil) but then increased from Dec. 2023 (₩-53 Mil) to Mar. 2024 (₩0 Mil).

Kolon Life Science's annual Other Net Income (Loss) declined from Dec. 2021 (₩-0 Mil) to Dec. 2022 (₩-1,883 Mil) but then increased from Dec. 2022 (₩-1,883 Mil) to Dec. 2023 (₩2,873 Mil).

Kolon Life Science Other Net Income (Loss) Historical Data

The historical data trend for Kolon Life Science's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon Life Science Other Net Income (Loss) Chart

Kolon Life Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

-1,882.96

2,873.03

Kolon Life Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															2,758.30	167.61	-	-52.88	-

Kolon Life Science Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩115 Mil.

Kolon Life Science Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Kolon Life Science's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kolon Life Science (XKRX:102940) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kolon Life Science Inc (XKRX:102940) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

110, Magokdong-ro, Gangseo-gu, One & Only Tower, Seoul, KOR

Website

http://www.kolonls.co.kr

Kolon Life Science Inc develops, manufactures and sells Biopharmaceuticals, Active pharmaceutical ingredients, Antimicrobials and Water solutions. Its products include Invossa, KLS-1010, KLS-2020, Azilsartan, Besfloc etc. The company has manufacturing facilities in Chungju, Eumsung and Kimchun.

Kolon Life Science (XKRX:102940) Headlines

No Headlines